Association between the anti-HHV-6A/B IgG titers at the 2-years visit with the progression of the disease (A) and the activity of the disease (B) after two years of treatment with the different DMTs.
<p>A. 9/18 MS patients with titers >44 PU after 2-years of treatment were free of progression vs. 39/54 with titers between 33–44 PU vs. 74/104 with titers between 22–33 PU vs. 82/108 with titers between 11–22 PU vs. 15/17 with titers <11 PU. B. 10/18 MS patients with titers >44 PU after 2-years of treatment were free of relapses vs. 37/54 with titers between 33–44 PU vs. 74/104 with titers between 22–33 PU vs. 80/108 with titers between 11–22 PU vs. 14/17 with titers <11 PU.</p
